Basic information Safety Related Supplier

ChemicalBook Product Catalog Biochemical Engineering Biochemical Reagents Agonist Inhibitors (Rac)-SAR131675

1/1

(Rac)-SAR131675 NEW

$120.00 5mg

$175.00 10mg

$292.00 25mg

Min. Order
Purity99.02%
Cas No1092539-44-0
Supply Ability10g
Update time2026-04-14

TargetMol Chemicals Inc.

TargetMol Chemicals Inc.

VIP6Y

United States

United States

show more

Enterprise Verified

Business Bank account Basic Contact Infomation Business Address Trade Company

Chemical Properties

Product Name	(Rac)-SAR131675
CAS No	1092539-44-0
EC-No
Min. Order
Purity	99.02%
Supply Ability	10g
Release date	2026/04/14

Product Introduction

Bioactivity

Name	(Rac)-SAR131675
Description	(Rac)-SAR131675 is an effective and specific VEGFR-3 inhibitor. It inhibited VEGFR-3 tyrosine kinase activity (IC50: 20 nmol/L) and VEGFR-3 autophosphorylation (IC50: 45 nmol/L) in HEK cells, respectively. SAR131675 is highly specific for VEGFR-3 versus 107 receptors, enzymes, ion channels, and 65 kinases. SAR131675 is a highly specific VEGFR-3-TK inhibitor with significant antitumoral and antimetastatic activities in vivo through inhibition of lymphangiogenesis and TAM invasion.
In vitro	SAR131675 dose dependently inhibits the proliferation of primary human lymphatic cells, induced by the VEGFR-3 ligands VEGFC and VEGFD, with an IC50 of about 20 nM. SAR131675 dose dependently inhibits rh-VEGFR-3–TK activity with an IC50 of 23 nM. SAR131675 inhibits VEGR-3–TK activity with a Ki of about 12 nM. SAR131675 inhibits VEGFR-1–TK activity with an IC50 of > 3 μM and VEGFR-2–TK activity with an IC50 of 235 nM. SAR131675 inhibits VEGFR-1 autophosphorylation with an IC50 of about 1 μM and VEGFR-2 with an IC50 of about 280 nM. SAR131675 moderately inhibits VEGFR-2 and has very little effect on VEGFR-1, showing a good selectivity for VEGFR-3. SAR131675 inhibits VEGFA-induced VEGFR-2 phosphorylation in a dose-dependent manner, with an IC50 of 239 nM. SAR131675 potently inhibits lymphatic cell survival induced by VEGFC and VEGFD with IC50 of 14 nM and 17 nM, respectively. SAR131675 inhibits VEGFA-induced survival with an IC50 of 664 nM. SAR131675, significantly and dose dependently inhibits VEGFC-induced Erk phosphorylation, with an IC50 of about 30 nM. [1]
Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information	DMSO : Slightly soluble
Keywords	VEGFR3 \| VEGFR \| Vascular endothelial growth factor receptor \| selective \| SAR-131675 \| SAR 131675 \| racemate \| potent \| Inhibitor \| inhibit \| (Rac)-SAR-131675 \| (Rac)-SAR131675 \| (Rac)SAR131675 \| (Rac) SAR131675
Inhibitors Related	Ribociclib \| Regorafenib monohydrate \| Sorafenib \| glycine \| Nintedanib esylate \| Regorafenib \| Ethyl cinnamate \| Chloramphenicol \| Thymoquinone \| Lenvatinib \| Pazopanib \| Albendazole
Related Compound Libraries	Anti-Lung Cancer Compound Library \| Anti-Colorectal Cancer Compound Library \| Bioactive Compound Library \| Membrane Protein-targeted Compound Library \| Kinase Inhibitor Library \| Tyrosine Kinase Inhibitor Library \| Inhibitor Library \| Anti-Fibrosis Compound Library \| NO PAINS Compound Library \| Bioactive Compounds Library Max \| Covalent Inhibitor Library \| Anti-Cancer Active Compound Library

show more

Company Profile Introduction

You may like

Recommended supplier

Send Inquriy